ABSTRACT
Moraxella catarrhalis is a human-restricted opportunistic bacterial pathogen of the respiratory mucosa. It frequently colonizes the nasopharynx asymptomatically, but is also an important causative agent of otitis media (OM) in children, and plays a significant role in acute exacerbations of chronic obstructive pulmonary disease (COPD) in adults. As the current treatment options for M. catarrhalis infection in OM and exacerbations of COPD are often ineffective, the development of an efficacious vaccine is warranted. However, no vaccine candidates for M. catarrhalis have progressed to clinical trials, and information regarding the distribution of M. catarrhalis virulence factors and vaccine candidates is inconsistent in the literature. It is largely unknown if virulence is associated with particular strains or subpopulations of M. catarrhalis, or if differences in clinical manifestation can be attributed to the heterogeneous expression of specific M. catarrhalis virulence factors in the circulating population. Further investigation of the distribution of M. catarrhalis virulence factors in the context of carriage and disease is required so that vaccine development may be targeted at relevant antigens that are conserved among disease-causing strains. The challenge of determining which of the proposed M. catarrhalis virulence factors are relevant to human disease is amplified by the lack of a standardized M. catarrhalis typing system to facilitate direct comparisons of worldwide isolates. Here we summarize and evaluate proposed relationships between M. catarrhalis subpopulations and specific virulence factors in the context of colonization and disease, as well as the current methods used to infer these associations.
Subject(s)
Moraxella catarrhalis/immunology , Moraxella catarrhalis/pathogenicity , Moraxellaceae Infections/immunology , Moraxellaceae Infections/microbiology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Bacterial Vaccines/immunology , Humans , Moraxella catarrhalis/classification , Moraxella catarrhalis/genetics , Moraxellaceae Infections/drug therapy , Moraxellaceae Infections/prevention & control , Otitis Media/drug therapy , Otitis Media/immunology , Otitis Media/microbiology , Otitis Media/prevention & control , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/immunology , Pulmonary Disease, Chronic Obstructive/microbiology , Pulmonary Disease, Chronic Obstructive/prevention & control , Virulence/genetics , Virulence/immunology , Virulence Factors/genetics , Virulence Factors/immunologyABSTRACT
Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic or emerging world-wide. Here we report unmarked allele-replacement mutagenesis using efficient sacB counter-selection. Despite being genotypically sacB(+), most commonly used B. pseudomallei strains are sucrose-resistant and efficient sacB counter-selection is demonstrated in both resistant and sensitive strains.
Subject(s)
Burkholderia pseudomallei/genetics , Mutagenesis, Site-Directed/methods , Sucrose/metabolism , Alleles , Burkholderia pseudomallei/metabolism , DNA, Bacterial/genetics , Gene Expression Regulation, Bacterial , Genes, Bacterial , Sequence DeletionABSTRACT
Neisseria meningitidis serogroup B is a major cause of bacterial meningitis in younger populations. The available vaccines are based on outer membrane vesicles obtained from wild-type strains. In children less than 2 years old they confer protection only against strains expressing homologous PorA, a major, variable outer membrane protein (OMP). We genetically modified a strain in order to eliminate PorA and to overproduce one or several minor and conserved OMPs. Using a mouse model mimicking children's PorA-specific bactericidal activity, it was demonstrated that overproduction of more than one minor OMP is required to elicit antibodies able to induce complement-mediated killing of strains expressing heterologous PorA. It is concluded that a critical density of bactericidal antibodies needs to be reached at the surface of meningococci to induce complement-mediated killing. With minor OMPs, this threshold is reached when more than one antigen is targeted, and this allows cross-protection.
Subject(s)
Anti-Bacterial Agents/pharmacology , Antibodies, Bacterial/pharmacology , Membrane Proteins/immunology , Neisseria meningitidis/immunology , Animals , Blood Bactericidal Activity , Drug Synergism , Female , Gene Deletion , Meningococcal Infections/immunology , Meningococcal Infections/prevention & control , Mice , Microbial Viability , Neisseria meningitidis/genetics , Porins/geneticsABSTRACT
Burkholderia pseudomallei is a facultative intracellular pathogen and the causative agent of melioidosis, a spectrum of potentially fatal diseases endemic in Northern Australia and South-East Asia. We demonstrate that B. pseudomallei rapidly modifies infected macrophage-like cells in a manner analagous to osteoclastogenesis. These alterations include multinucleation and the expression by infected cells of mRNA for factors required for osteoclastogenesis: the chemokines monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 1 gamma (MIP-1gamma), 'regulated on activation normal T cell expressed and secreted' (RANTES) and the transcription factor 'nuclear factor of activated T-cells cytoplasmic 1' (NFATc1). An increase in expression of these factors was also observed after infection with Burkholderia thailandensis. Expression of genes for the osteoclast markers calcitonin receptor (CTR), cathepsin K (CTSK) and tartrate-resistant acid phosphatase (TRAP) was also increased by B. pseudomallei-infected, but not by B. thailandensis-infected cells. The expression by B. pseudomallei-infected cells of these chemokine and osteoclast marker genes was remarkably similar to cells treated with RANKL, a stimulator of osteoclastogenesis. Analysis of dentine resorption by B. pseudomallei-induced osteoclast-like cells revealed that demineralization may occur but that authentic excavation does not take place under the tested conditions. Furthermore, we identified and characterized lfpA (for lactonase family protein A) in B. pseudomallei, which shares significant sequence similarity with the eukaryotic protein 'regucalcin', also known as 'senescence marker protein-30' (SMP-30). LfpA orthologues are widespread in prokaryotes and are well conserved, but are phylogenetically distinct from eukaryotic regucalcin orthologues. We demonstrate that lfpA mRNA expression is dramatically increased in association with macrophage-like cells. Mutation of lfpA significantly reduced expression of the tested host genes, relative to the response to wild-type B. pseudomallei. We also show that lfpA is required for optimal virulence in vivo.
Subject(s)
Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/immunology , Giant Cells/physiology , Melioidosis/immunology , Osteoclasts/metabolism , Receptors, Calcitonin/metabolism , Animals , Burkholderia pseudomallei/physiology , Calcitonin/metabolism , Cell Differentiation/physiology , Cell Line , Cricetinae , Disease Models, Animal , Giant Cells/metabolism , Melioidosis/genetics , Melioidosis/microbiology , Mesocricetus , Osteoclasts/cytologyABSTRACT
The Burkholderia pseudomallei K96243 genome contains multiple type IV pilin-associated loci, including one encoding a putative pilus structural protein (pilA). A pilA deletion mutant has reduced adherence to human epithelial cells and is less virulent in the nematode model of virulence and the murine model of melioidosis, suggesting a role for type IV pili in B. pseudomallei virulence.
Subject(s)
Bacterial Adhesion/physiology , Burkholderia pseudomallei/metabolism , Fimbriae Proteins/metabolism , Fimbriae, Bacterial/metabolism , Animals , Bacterial Adhesion/genetics , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/pathogenicity , Caenorhabditis elegans/metabolism , Caenorhabditis elegans/microbiology , Cells, Cultured , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Fimbriae, Bacterial/genetics , Humans , Mice , Time FactorsABSTRACT
A repetitive DNA motif was used as a marker to identify novel genes in the mucosal pathogen Moraxella catarrhalis. There is a high prevalence of such repetitive motifs in virulence genes that display phase variable expression. Two repeat containing loci were identified using a digoxigenin-labelled 5'-(CAAC)6-3' oligonucleotide probe. The repeats are located in the methylase components of two distinct type III restriction-modification (R-M) systems. We suggest that the phase variable nature of these R-M systems indicates that they have an important role in the biology of M. catarrhalis.